1-3 of 3
Dmitri B. Kirpotin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Free
Helen Lee, Anthony F. Shields, Barry A. Siegel, Kathy D. Miller, Ian Krop, Cynthia X. Ma, Patricia M. LoRusso, Pamela N. Munster, Karen Campbell, Daniel F. Gaddy, Shannon C. Leonard, Elena Geretti, Stephanie J. Blocker, Dmitri B. Kirpotin, Victor Moyo, Thomas J. Wickham, Bart S. Hendriks
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4190–4202.
https://doi.org/10.1158/1078-0432.CCR-16-3193
Published: 01 August 2017
View articletitled, 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Open the PDF for 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes

Free
Daryl C. Drummond, Corina Marx, Zexiong Guo, Gary Scott, Charles Noble, Donghui Wang, Maria Pallavicini, John W. Park, Dmitri B. Kirpotin, Christopher C. Benz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3392–3401.
https://doi.org/10.1158/1078-0432.CCR-04-2445
Published: 02 May 2005
View articletitled, Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes
Open the PDF for Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes in another window
Journal Articles

Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery

Free
John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, Jose Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan Moore, Demetrios Papahadjopoulos, Christopher C. Benz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1172–1181.
Published: 01 April 2002
View articletitled, Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery
Open the PDF for Anti-HER2 Immunoliposomes: Enhanced Efficacy Attributable to Targeted Delivery in another window